Free Shipping over $200

RT3

0.0 (0 reviews)

A synthetic, lipidated peptide engineered as a triple agonist of the glucagon-like peptide-1 receptor (GLP-1R), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon receptor (GCGR). Its multi-receptor pharmacology makes it of interest in research examining receptor activation, downstream signaling pathways, metabolic regulation, energy homeostasis, and peptide structure–activity relationships. Retatrutide may also be studied in experimental models evaluating the combined effects of incretin and glucagon receptor signaling.

For laboratory research use only. Not for human or veterinary use.

Price range: $109.99 through $389.99
Customer Support
Secure Checkout
Fast USA Shipping
99% Purity
3rd-Party Tested
Product Guarantee

Purity Verification

At Beltrix, every compound undergoes rigorous identity verification and purity testing before batch release, ensuring exceptional quality, consistency, and compliance with strict laboratory standards.

Each batch is 6x tested through

  • HPLC purity analysis
  • Identity confirmation
  • Endotoxins
  • Sterility
  • Heavy Metals
  • Conformity
PURITY SPECIFICATIONS EXCEED 99% HPLC FOR APPLICABLE COMPOUNDS.

Product Information

Description

This product is supplied as a lyophilized powder for in-vitro laboratory research use only. Batch-specific Certificate of Analysis available for download above. Not for human or animal use.

Additional information

strength

5mg, 10mg, 20mg, 30mg, 40mg

Customer Reviews

0.0

Based on 0 reviews

5 star
0%
4 star
0%
3 star
0%
2 star
0%
1 star
0%

Your email address will not be published. Required fields are marked *

Trust & Certifications

Laboratory is GMP and ISO Certified
Secure Payment
Authentic Guarantee
STEP 1 OF 2

Age verification

Beltrix Labs products are available only to customers 21 years of age or older. Please confirm your age to continue.

STEP 2 OF 2

Research use only

Beltrix Labs peptides are for in-vitro laboratory research. Please confirm your intended use.